---
title: "Devonian Health Brief: Revenue for Dexlansoprazole represented 86% and 92% of total reported revs for fiscal year ended July 31, 2024, and quarter ended October 31,2024, respectively"
date: "2025-02-08 06:09:59"
summary: ""
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---



[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250207:A3313086:0/)
